Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tito R Mendoza

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Neuro-Oncology|May 26, 2021
Especially for neuro-oncologists-minimally important differences for the EORTC QLQ-C30 in glioma patientsTito R Mendoza
Advances in Experimental Medicine and Biology|April 18, 2020
New Developments in the Use of Patient-Reported Outcomes in Cancer Patients Undergoing ImmunotherapiesTito R Mendoza
Advances in Experimental Medicine and Biology|December 13, 2018
Symptoms as Patient-Reported Outcomes in Cancer Patients Undergoing ImmunotherapiesTito R Mendoza
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 20, 2014
Response to Lai et al., "development of a symptom index for patients with primary brain tumors"Terri S Armstrong, Tito R Mendoza
The Journal of Investigative Dermatology. Symposium Proceedings|December 24, 2017
The Utility and Validity of the Alopecia Areata Symptom Impact Scale in Measuring Disease-Related Symptoms and their Effect on FunctioningTito R Mendoza, Joyce Osei, Madeleine Duvic
Neuro-Oncology Practice|August 7, 2019
Opportunities and challenges of incorporating clinical outcome assessments in brain tumor clinical trialsEmanuela Molinari, Tito R Mendoza, Mark R Gilbert
Medical Care|April 16, 2019
Interpreting Patient-reported Outcome Scores for Clinical Research and Practice: Definition, Determination, and Application of CutpointsQiuling Shi, Tito R Mendoza, Charles S Cleeland
The Journal of Investigative Dermatology. Symposium Proceedings|December 12, 2013
Development of the alopecia areata symptom impact scaleTito R Mendoza, Joyce S Osei, Qiuling Shi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2016
Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancerQiuling Shi, Tito R Mendoza, Xin Shelley Wang, et al.
The Clinical Journal of Pain|April 22, 2004
Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case seriesAllen W Burton, Larry C Driver, Tito R Mendoza, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Neuro-Oncology|May 26, 2021
Especially for neuro-oncologists-minimally important differences for the EORTC QLQ-C30 in glioma patientsTito R Mendoza
Advances in Experimental Medicine and Biology|April 18, 2020
New Developments in the Use of Patient-Reported Outcomes in Cancer Patients Undergoing ImmunotherapiesTito R Mendoza
Advances in Experimental Medicine and Biology|December 13, 2018
Symptoms as Patient-Reported Outcomes in Cancer Patients Undergoing ImmunotherapiesTito R Mendoza
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 20, 2014
Response to Lai et al., "development of a symptom index for patients with primary brain tumors"Terri S Armstrong, Tito R Mendoza
The Journal of Investigative Dermatology. Symposium Proceedings|December 24, 2017
The Utility and Validity of the Alopecia Areata Symptom Impact Scale in Measuring Disease-Related Symptoms and their Effect on FunctioningTito R Mendoza, Joyce Osei, Madeleine Duvic
Neuro-Oncology Practice|August 7, 2019
Opportunities and challenges of incorporating clinical outcome assessments in brain tumor clinical trialsEmanuela Molinari, Tito R Mendoza, Mark R Gilbert
Medical Care|April 16, 2019
Interpreting Patient-reported Outcome Scores for Clinical Research and Practice: Definition, Determination, and Application of CutpointsQiuling Shi, Tito R Mendoza, Charles S Cleeland
The Journal of Investigative Dermatology. Symposium Proceedings|December 12, 2013
Development of the alopecia areata symptom impact scaleTito R Mendoza, Joyce S Osei, Qiuling Shi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2016
Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancerQiuling Shi, Tito R Mendoza, Xin Shelley Wang, et al.
The Clinical Journal of Pain|April 22, 2004
Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case seriesAllen W Burton, Larry C Driver, Tito R Mendoza, et al.
Pageof 16